Table 2 Serum analysis
Analysis | All (n = 121) | Responders (n = 73) | Non-responders (n = 48) | P-value |
|---|---|---|---|---|
s-TNF (pg/mL) | 0 (0 to 1,212) | 0 (0 to 1,212) | 0 (0 to 99) | 0.399 |
s-IL6 (pg/mL) | 14 (0 to 324) | 30 (0 to 24) | 7 (0 to 324) | 0.629 |
s-VEGF (pg/mL) | 218 (0 to 1,750) | 218 (0 to 1,188) | 212 (0 to 1,750) | 0.850 |
s-MMP3 (pg/mL) | 138 (16 to 116,714) | 138 (16 to 116,714) | 140 (34 to 52,031) | 0.911 |
s-COMP (U/L) | 10.7 ± 3.4 | 10.8 ± 3.9 | 10.5 ± 2.5 | 0.636 |
s–anti-CCP (>7 IU/ml) | 87/121 (72%) | 48/73 (66%) | 39/48 (81%) | 0.064 |
s-IgM-RF (>5 IU/ml) | 90/121 (74%) | 51/73 (70%) | 39/48 (81%) | 0.160 |
s-ANA | 38/99 (38%) | 14/39 (36%) | 24/60 (33%) | 0.682 |